Verastem and VS-7375
Verastem has a phase 2 trial fastracked by the FDA of VS-7375 aimed at pancreatic, lung and colorectal cancer. As stated in their last earnings report "we look forward to sharing additional clinical data in October" , so next month can be a good catalyst, also just today they announced that they will be in a healthcare conference on september 8, another one on september 10, and an investment conference on september 14. You don't line up 3 conferences the month previous to share more clinical data if you know it is going to be bad, but I don't like betting on hopium, so I googled what the patients in those trials have been saying about it: These are from reddit https://preview.redd.it/utu9w52x36nh1.png?width=1155&format=png&auto=webp&s=f4c8fc0bbe6763208a9e0259578cc969c97bd396 https://preview.redd.it/yo995g8m66nh1.png?width=1104&format=png&auto=webp&s=356d27b33fe29e6e89ad58ba3138ed6daca6e12c And this from facebook: https://preview.redd.it/jm2rdobd46nh1.png?width=5
重要性：RSS 导入条目，等待编辑或代理补充市场影响解读。